Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues

Journal of Histochemistry and Cytochemistry

Volumn 57, Issue 5, 2009, Pages 477-489

  Dietrich, Dimo ^a   Lesche, Ralf ^a   Tetzner, Reimo ^a   Krispin, Manuel ^a   Dietrich, Jörn ^a   Haedicke, Wolfgang ^b   Schuster, Matthias ^a   Kristiansen, Glen ^c  

^a EPIGENOMICS AG   (Germany)

^b MVZ Vorpommern GmbH   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Breast cancer; DNA methylation; Formalin fixed and paraffin embedded tissues; Laser microdissection; Multiplexed analysis; Quantitative bisulfite sequencing

Indexed keywords

CALNEXIN; DNA; HEPARAN SULFATE; HS3ST2 PROTEIN; LIM KINASE 1; NUCLEIC ACID BINDING PROTEIN; PLAUNOTOL; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SLIT2 PROTEIN; SLITRK1 PROTEIN; TFF1 PROTEIN; TRANSCRIPTION FACTOR LHX3; TRANSCRIPTION FACTOR PITX2; TRANSCRIPTION FACTOR PITX3; TREFOIL PEPTIDE; UNCLASSIFIED DRUG; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; FIXATIVE; FORMALDEHYDE; HYDROGEN SULFITE; PARAFFIN; SULFITE; TUMOR MARKER;

ADIPOSE TISSUE; ARTICLE; BREAST; BREAST CANCER; CONTROLLED STUDY; DNA METHYLATION; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; BREAST TUMOR; CHEMISTRY; DNA SEQUENCE; FEMALE; FIBROCYSTIC BREAST DISEASE; GENETICS; LASER; METHODOLOGY; MICRODISSECTION; PAGET NIPPLE DISEASE; PATHOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; STROMA CELL; TUMOR ASSOCIATED LEUKOCYTE;

ADIPOSE TISSUE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DNA METHYLATION; FEMALE; FIBROCYSTIC BREAST DISEASE; FIXATIVES; FORMALDEHYDE; HUMANS; INDICATORS AND REAGENTS; LASERS; LYMPHOCYTES, TUMOR-INFILTRATING; MICRODISSECTION; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; STROMAL CELLS; SULFITES; TUMOR MARKERS, BIOLOGICAL;

EID: 66149114095     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2009.953026     Document Type: Article

References (55)

1. Aitchison A, Warren A, Neal D, Rabbitts P (2007) RASSF1A promoter methylation is frequently detected in both pre-malignant and non-malignant microdissected prostatic epithelial tissues. Prostate 67:638-644
2. Arriola E, Lambros MB, Jones C, Dexter T, Mackay A, Tan DS, Tamber N, et al. (2007) Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation. Lab Invest 87:75-83
3. Bae YK, Brown A, Garrett E, Bornman D, Fackler MJ, Sukumar S, Herman JG, et al. (2004) Hypermethylation in histologically distinct classes of breast cancer. Clin Cancer Res 10:5998-6005
4. Charles MA, Suh H, Hjalt TA, Drouin J, Camper SA, Gage PJ (2005) PITX genes are required for cell survival and Lhx3 activation. Mol Endocrinol 19:1893-1903
5. Cui J, Rohr LR, Swanson G, Speights VO, Maxwell T, Brothman AR (2001) Hypermethylation of the caveolin-1 gene promoter in prostate cancer. Prostate 46:249-256
6. Dean FB, Hosono S, Fang L, Wu X, Faruqi AF, Bray-Ward P, Sun Z, et al. (2002) Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci USA 99: 5261-5266
7. Di Vinci A, Perdelli L, Banelli B, Salvi S, Casciano I, Gelvi I, Allemanni G, et al. (2005) p16(INK4a) promoter methylation and protein expression in breast fibroadenoma and carcinoma. Int J Cancer 114:414-421
8. Esposito G (2007) Complementary techniques: laser capture microdissection-increasing specificity of gene expression profiling of cancer specimens. Adv Exp Med Biol 593:54-65
9. Fackler MJ, Malone K, Zhang Z, Schilling E, Garrett-Mayer E, Swift-Scanlan T, Lange J, et al. (2006) Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res 12:3306-3310
10. Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, Lapides A, Garrett E, et al. (2004) Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 64:4442-4452
11. Foekens JA, Rio MC, Seguin P, van Putten WL, Fauque J, Nap M, Klijn JG, et al. (1990) Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res 50:3832-3837
12. Fraga MF, Esteller M (2002) DNA methylation: a profile of methods and applications. Biotechniques 33:632-649
13. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, et al. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89:1827-1831
14. Greenspan EJ, Jablonski MA, Rajan TV, Levine J, Belinsky GS, Rosenberg DW (2006) Epigenetic alterations in RASSF1A in human aberrant crypt foci. Carcinogenesis 27:1316-1322
15. Guarino M, Rubino B, Ballabio G (2007) The role of epithelialmesenchymal transition in cancer pathology. Pathology 39:305-318
16. Han W, Cauchi S, Herman JG, Spivack SD (2006) DNA methylation mapping by tag-modified bisulfite genomic sequencing. Anal Biochem 355:50-61
17. Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, et al. (2006) Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst 98:255-261
18. Henrique R, Jeronimo C, Teixeira MR, Hoque MO, Carvalho AL, Pais I, Ribeiro FR, et al. (2006) Epigenetic heterogeneity of highgrade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis. Mol Cancer Res 4:1-8
19. Hoque MO, Feng Q, Toure P, Dem A, Critchlow CW, Hawes SE, Wood T, et al. (2006) Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol 24:4262-4269
20. Hui R, Macmillan RD, Kenny FS, Musgrove EA, Blamey RW, Nicholson RI, Robertson JF, et al. (2000) INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis. Clin Cancer Res 6:2777-2787
21. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428
22. Lehmann U, Kreipe H (2004) Real-time PCR-based assay for quantitative determination of methylation status. Methods Mol Biol 287:207-218
23. Lehmann U, Langer F, Feist H, Glockner S, Hasemeier B, Kreipe H (2002) Quantitative assessment of promoter hypermethylation during breast cancer development. Am J Pathol 160:605-612
24. Lesche R, Fassbender A, Juenemann K, Foekens JA, Martens JWM (2006) Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders. Patent WO2006008128
25. Lewin J, Schmitt AO, Adorjan P, Hildmann T, Piepenbrock C (2004) Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics 20:3005-3012
26. L'Honore A, Coulon V, Marcil A, Lebel M, Lafrance-Vanasse J, Gage P, Camper S, et al. (2007) Sequential expression and redundancy of Pitx2 and Pitx3 genes during muscle development. Dev Biol 307:421-433
27. Li H, Fan X, Houghton J (2007) Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 101:805-815
28. Liu L, Wylie RC, Hansen NJ, Andrews LG, Tollefsbol TO (2004) Profiling DNA methylation by bisulfite genomic sequencing: problems and solutions. Methods Mol Biol 287:169-179
29. Lodygin D, Diebold J, Hermeking H (2004) Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression. Oncogene 23:9034-9041
30. Maier S, Nimmrich I, Koenig T, Eppenberger-Castori S, Bohlmann I, Paradiso A, Spyratos F, et al. (2007) DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients: technical and clinical validation in a multicentre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. Eur J Cancer 43:1679-1686
31. Martin V, Ribieras S, Song-Wang X, Rio MC, Dante R (1995) Genomic sequencing indicates a correlation between DNA hypomethylation in the 5′ region of the pS2 gene and its expression in human breast cancer cell lines. Gene 157:261-264
32. Muller HM, Fiegl H, Widschwendter A, Widschwendter M (2004) Prognostic DNA methylation marker in serum of cancer patients. Ann N Y Acad Sci 1022:44-49
33. Nakayama M, Bennett CJ, Hicks JL, Epstein JI, Platz EA, Nelson WG, De Marzo AM (2003) Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol 163:923-933
34. Nimmrich I, Sieuwerts AM, Meijer-van Gelder ME, Schwope I, Bolt-de Vries J, Harbeck N, Koenig T, et al. (2008) DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients. Breast Cancer Res Treat 111:429-437
35. Paez JG, Lin M, Beroukhim R, Lee JC, Zhao X, Richter DJ, Gabriel S, et al. (2004) Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification. Nucleic Acids Res 32:e71
36. Pakneshan P, Szyf M, Rabbani SA (2005) Hypomethylation of urokinase (uPA) promoter in breast and prostate cancer: prognostic and therapeutic implications. Curr Cancer Drug Targets 5:471-488
37. Pakneshan P, Tetu B, Rabbani SA (2004) Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma. Clin Cancer Res 10:3035-3041
38. Rakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, Gräf S, Tomazou EM, et al. (2008) An integrated resource for genomewide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res 18:1518-1529
39. Robertson KD (2005) DNA methylation and human disease. Nat Rev Genet 14:597-610
40. Rodriguez-Canales J, Hanson JC, Tangrea MA, Erickson HS, Albert PS, Wallis BS, Richardson AM, et al. (2007) Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol 211:410-419
41. Ruibal A, Schneider J, del Rio C, Arias J, Nunez MJ, Piqueras V, Tejerina A (1999) pS2 negativity in post-menopausal women with ER1PgR1 infiltrating ductal breast carcinoma is associated with reduced hormone dependence and increased proliferation and aneuploidy of the tumors. Int J Biol Markers 14:186-188
42. Schwartz LH, Koerner FC, Edgerton SM, Sawicka JM, Rio MC, Bellocq JP, Chambon P, et al. (1991) pS2 expression and response to hormonal therapy in patients with advanced breast cancer. Cancer Res 51:624-628
43. Shinozaki M, Hoon DS, Giuliano AE, Hansen NM, Wang HJ, Turner R, Taback B (2005) Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Clin Cancer Res 11:2156-2162
44. Soltermann A, Tischler V, Arbogast S, Braun J, Probst-Hensch N, Weder W, Moch H, et al. (2008) Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 14:7430-7437
45. Srinivasan M, Sedmak D, Jewell S (2002) Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 161:1961-1971
46. Tanaka K, Okamoto A (2007) Degradation of DNA by bisulfite treatment. Bioorg Med Chem Lett 17:1912-1915
47. Tetzner R, Dietrich D, Distler J (2007) Control of carry-over contamination for PCR-based DNA methylation quantification using bisulfite treated DNA. Nucleic Acids Res 35:e4
48. Tost J, Dunker J, Gut IG (2003) Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing. Biotechniques 35:152-156
49. Tost J, Gut IG (2007) DNA methylation analysis by pyrosequencing. Nat Protocols 2:2265-2275
50. Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S (2001) Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 20:3348-3353
51. Witz IP (2008) Tumor-microenvironment interactions: dangerous liaisons. Adv Cancer Res 100:203-229
52. Woodson K, Gillespie J, Hanson J, Emmert-Buck M, Phillips JM, Linehan WM, Tangrea JA (2004) Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens. Prostate 60:25-31
53. Yan PS, Venkataramu C, Ibrahim A, Liu JC, Shen RZ, Diaz NM, Centeno B, et al. (2006) Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res 12:6626-6636
54. Yang WH, Wu JR, Wang TH, Au LC (2007) Methylation profiling using degenerated oligonucleotide primer-PCR specific for genome-wide amplification of bisulfite-modified DNA. Anal Biochem 369:120-127
55. Zeschnigk M, Bohringer S, Price EA, Onadim Z, Masshöfer L, Lohmann DR (2004) A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus. Nucleic Acids Res 32:e125